Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

about

Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer.

P2860

Q38522309-0857FAE2-AD49-47AC-A694-35592E861198

P2860

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

Item

http://www.wikidata.org/entity/Q38020145

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

@en

type

Item

label

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

@en

prefLabel

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

@en

P1476

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond

@en

P2093

Sai-Juan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.

Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector

Retinoic acid and arsenic for treating acute promyelocytic leukemia

Global cancer statistics, 2002

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

P304

671-675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IUB.1055

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guangbiao Zhou

G Zhou

P577

2012-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227400561

http://www.w3.org/2001/XMLSchema#string

P698

22714999

http://www.w3.org/2001/XMLSchema#string

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

about

P2860

P2860

Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698